» Articles » PMID: 25715989

Discrepancies in Describing Pain: is There Agreement Between Numeric Rating Scale Scores and Pain Reduction Percentage Reported by Patients with Musculoskeletal Pain After Corticosteroid Injection?

Overview
Journal Pain Med
Date 2015 Feb 27
PMID 25715989
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Pain intensity is commonly rated on an 11-point Numerical Pain Rating Scale which can be expressed as a calculated percentage pain reduction (CPPR), or by patient-reported percentage pain reduction (PRPPR). We aimed to determine the agreement between CPPR and PRPPR in quantifying musculoskeletal pain improvement at short-term follow-up after a corticosteroid injection.

Design: Retrospective cohort study.

Setting: Urban, academic, physical medicine, and rehabilitation outpatient interventional musculoskeletal and spine center.

Methods: The agreement between CPPR and PRPPR was determined by concordance correlation coefficient (CCC) in subjects who had experienced improvement in musculoskeletal or radicular pain 3 weeks after a first-time injection at our clinic. Subjects who experienced unchanged pain (PRPPR = 0) were compared to CPPR with paired t-test.

Results: We examined 197 subjects with greater than 3/10 pain who underwent first-time fluoroscopic-guided corticosteroid injections. Ninety-three subjects reported higher PRPPR than CPPR values, and 41 subjects reported higher CPPR values. The CCC between CPPR and PRPPR was 0.44 (95% CI 0.35-0.54), with a precision of 0.54 and an accuracy of 0.81, and 95% limits of agreement ranging between -41% and +73%. Values for CCC, precision, and accuracy were higher for males compared to females and were highest in the youngest age group (18-40) and lowest in the middle age group (41-60).

Conclusions: PRPPR may not agree with CPPR at 3 week follow-up, as these individuals tend to report a higher estimated percentage improvement compared to the value calculated from their pain scores.

Citing Articles

A single-center real-world review of 10 kHz high-frequency spinal cord stimulation outcomes for treatment of chronic pain.

Ehsanian R, Wu V, Grandhe R, Valeriano M, Petersen T, Rivers W Interv Pain Med. 2024; 3(1):100402.

PMID: 39239496 PMC: 11373048. DOI: 10.1016/j.inpm.2024.100402.


The Discrepancy and Agreement between Patient-Reported Percentage Pain Reduction and Calculated Percentage Pain Reduction in Chronic Pain Patients.

Fink A, Ong C, Sumar M, Patel N, Knezevic N Neurol Int. 2023; 15(2):560-568.

PMID: 37092506 PMC: 10123715. DOI: 10.3390/neurolint15020034.


Patients' strategies for numeric pain assessment: a qualitative interview study of individuals with hypermobile Ehlers-Danlos Syndrome.

Halverson C, Doyle T Disabil Rehabil. 2023; 46(8):1527-1533.

PMID: 37067184 PMC: 10579449. DOI: 10.1080/09638288.2023.2200039.


Evolving Attitudes Toward Numeric Pain Assessment Among Patients with Hypermobile Ehlers-Danlos Syndrome: A Qualitative Interview Study.

Halverson C, Kroenke K, Penwell H, Francomano C Pain Med. 2022; 24(6):713-715.

PMID: 36322007 PMC: 10501462. DOI: 10.1093/pm/pnac167.


Intra-Articular Injection of Amniotic Membrane and Umbilical Cord Particulate for the Management of Moderate to Severe Knee Osteoarthritis.

Mead O, Mead L Orthop Res Rev. 2020; 12:161-170.

PMID: 33116955 PMC: 7585522. DOI: 10.2147/ORR.S272980.